Hofseth Biocare ASA: Mandatory notification of trade, primary insider in HBC
| Source: Hofseth Biocare ASA
Recommended Reading
-
Hofseth BioCare ASA ("HBC") announces that its US spin-out AecorBio Inc. ("AecorBio") has appointed Prof. Karl G. Sylvester, M.D., as Co-Founder and Consulting Chief Medical Officer. Dr. Sylvester is...
Read More -
Reference is made to the stock exchange announcement by Hofseth BioCare ASA (the "Company") from 28 June 2026 regarding the successful placing of a private placement of new Ordinary Shares in the...
Read More